Literature DB >> 20664768

Prevalence of mitral valve prolapse and associated valvular regurgitations in healthy teenagers undergoing screening echocardiography.

Sudhakar Sattur1, Sharon Bates, Mohammad Reza Movahed.   

Abstract

BACKGROUND: The true prevalence of mitral valve prolapse (MVP) in the population has been controversial.
OBJECTIVE: To evaluate the prevalence of MVP and associated valvular abnormalities in healthy teenage students.
METHODS: The Anthony Bates Foundation performed screening echocardiography in high schools across the United States. A total of 2072 students between 13 and 19 years of age were identified for the present study.
RESULTS: Total prevalence of MVP was 0.7%. The prevalence of MVP was significantly higher among female teenagers (nine of 690 female teenagers [1.3%] versus five of 1382 male teenagers [0.4%], P=0.01, OR 3.6, CI 1.21 to 10.70). The prevalence of mitral regurgitation (MR) and tricuspid regurgitation (TR) was higher in teenagers with MVP. MR occurred in five of 14 teenagers (35.7%) with MVP versus 15 of 2058 controls (0.7%) (P<0.001, OR 75.6, CI 22.6 to 252.5). TR occurred in one of 14 teenagers (7.1%) with MVP versus nine of 2058 controls (0.4%) (P<0.001, OR 17.5, CI 2.0 to 148.3).
CONCLUSION: The prevalence of MVP in this cohort of healthy teenage students was less than 1%. Furthermore, the prevalence of MVP was higher in female teenagers and was associated with a higher prevalence of MR and TR.

Entities:  

Keywords:  Adolescence; MVP; Mitral valvar prolapse; Screening; Teenagers; Valvular disease

Year:  2010        PMID: 20664768      PMCID: PMC2907880     

Source DB:  PubMed          Journal:  Exp Clin Cardiol        ISSN: 1205-6626


  14 in total

1.  The prevalence of mitral valve prolapse in patients undergoing echocardiography for clinical reason.

Authors:  Absalom D Hepner; Mastaneh Ahmadi-Kashani; Mohammad-Reza Movahed
Journal:  Int J Cardiol       Date:  2007-02-12       Impact factor: 4.164

2.  Non-ejection systolic clicks and mitral systolic murmurs in black schoolchildren of Soweto, Johannesburg.

Authors:  M J McLaren; D M Hawkins; A S Lachman; J B Lakier; W A Pocock; J B Barlow
Journal:  Br Heart J       Date:  1976-07

3.  Familial syndrome of midsystolic click and late systolic murmur.

Authors:  P Rizzon; G Biasco; G Brindicci; F Mauro
Journal:  Br Heart J       Date:  1973-03

4.  Effect of transducer placement on echocardiographic mitral valve motion.

Authors:  W Markiewicz; E London; R L Popp
Journal:  Am Heart J       Date:  1978-10       Impact factor: 4.749

5.  Mitral valve prolapse in the general population. 2. Clinical features: the Framingham Study.

Authors:  D D Savage; R B Devereux; R J Garrison; W P Castelli; S J Anderson; D Levy; H E Thomas; W B Kannel; M Feinleib
Journal:  Am Heart J       Date:  1983-09       Impact factor: 4.749

6.  Contribuiton of M-mode echocardiography to cardiac diagnosis. An assessment in 1,000 successive patients.

Authors:  W Markiewicz; B Peled; H Hammerman; Z Greif; J Hir; E Riss
Journal:  Am J Med       Date:  1978-11       Impact factor: 4.965

7.  Prevalence and clinical outcome of mitral-valve prolapse.

Authors:  L A Freed; D Levy; R A Levine; M G Larson; J C Evans; D L Fuller; B Lehman; E J Benjamin
Journal:  N Engl J Med       Date:  1999-07-01       Impact factor: 91.245

Review 8.  ACC/AHA guidelines for the management of patients with valvular heart disease. A report of the American College of Cardiology/American Heart Association. Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease).

Authors: 
Journal:  J Am Coll Cardiol       Date:  1998-11       Impact factor: 24.094

9.  Prevalence of mitral valve prolapse in normal children.

Authors:  D C Warth; M E King; J M Cohen; V L Tesoriero; E Marcus; A E Weyman
Journal:  J Am Coll Cardiol       Date:  1985-05       Impact factor: 24.094

10.  Natural history of mitral valve prolapse.

Authors:  A Zuppiroli; M Rinaldi; R Kramer-Fox; S Favilli; M J Roman; R B Devereux
Journal:  Am J Cardiol       Date:  1995-05-15       Impact factor: 2.778

View more
  5 in total

1.  Prevalence of Structural Heart Diseases Detected by Handheld Echocardiographic Device in School-Age Children in Iran: The SHED LIGHT Study.

Authors:  Saeid Hosseini; Niloufar Samiei; Avisa Tabib; Hooman Bakhshandeh; Yousef Rezaei; Mozhgan Parsaee; Fariba Rashidi Ghader; Maryam Moradian; Maryam Shojaeifard; Zahra Khajali; Sepideh Taghavi; Nasim Naderi; Golnar Mortaz Hejri; Homa Ghaderian; Golnaz Houshmand; Raheleh Kaviani; Melody Farrashi; Marzieh Pakbaz; Hoda Mombeini; Sedigheh Saedi; Alireza Alizadeh Ghavidel; Gholamreza Omrani; Ahmad Mohebbi; Mohammad Mehdi Peighambari; Mohammad Rafie Khorgami; Akbar Nikpajouh; Ahmad Amin; Majid Maleki; Carlos A Mestres; Luigi Paolo Badano; Feridoun Noohi
Journal:  Glob Heart       Date:  2022-06-15

2.  Autonomic dysregulation as a novel underlying cause of mitral valve prolapse: a hypothesis.

Authors:  Xiang Hu; Qiang Zhao
Journal:  Med Sci Monit       Date:  2011-09

Review 3.  Familial Screening for Left-Sided Congenital Heart Disease: What Is the Evidence? What Is the Cost?

Authors:  Daniel J Perry; Connor R Mullen; Horacio G Carvajal; Anoop K Brar; Pirooz Eghtesady
Journal:  Diseases       Date:  2017-12-08

4.  Concomitant cardiovascular malformations in isolated bicuspid aortic valve disease: a retrospective cross-sectional study and meta-analysis.

Authors:  Katalin Szöcs; Betül Toprak; Gerhard Schön; Meike Rybczynski; Tatjana Brinken; Adrian Mahlmann; Evaldas Girdauskas; Stefan Blankenberg; Yskert von Kodolitsch
Journal:  Cardiovasc Diagn Ther       Date:  2022-08

5.  An assessment of health status and health behaviours in adolescents: main points and methods of the SOPKARD-Junior programme.

Authors:  Klaudia Suligowska; Piotr Czarniak; Michał Krawczyk; Przemysław Szcześniak; Ewa Król; Aida Kusiak; Robert Sabiniewicz; Tomasz Wierzba; Alicja Utracka; Magdalena Urban; Anna Wytrykowska; Anna Pakalska; Konrad Drewek; Anna Giczewska; Piotr Popowski; Magdalena Wrotkowska; Joanna Marczulin; Mariusz Bochniak; Tomasz Zdrojewski
Journal:  Arch Med Sci       Date:  2016-11-17       Impact factor: 3.318

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.